RxDoctor Payments Data

Brett Robin, MD

Orthopaedic Surgery · Austin, TXNPI 1861649717

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medacta USA, Inc. at 53.7% of the total.

$32,533in general payments, 2019–2025

Across 183 payments — averaging $177.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$17K
  • Arthrex$5K
  • Pylant Medical$4K
  • Exactech, Inc.$3K
  • Miach Orthopaedics, Inc.$786
  • Stryker$512
  • plus $2K from 21 others
$32,442in research payments, 2019–2025

Across 6 payments — averaging $5407.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Anika Therapeutics, Inc.$32K

What the payments were for

  • Consulting fees$4,00012%
  • Travel & lodging$16,52051%
  • Food & beverage$7,93624%
  • Education$4,07713%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,533 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$144,089
Medicare patients
244
Services billed
1,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen108$1,030
Celecoxib35$1,007
Ondansetron Hcl64$522
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$263

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →